Chiara Frairia

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 3

Top Topics

Sickle Cell Disease

Prognostic Factors

Acute Respiratory Distress Syndrome

Patient Reported Outcomes

Top Venues

British journal of haematology

European journal of haematology

Azienda Ospedaliero-Universitaria Maggiore della Carità

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Azienda Ospedaliero-Universitaria Maggiore della Carità Nov 02 2015

Italy

MD :: Hemathology

Azienda Ospedaliero-Universitaria Citta della Salute e della Scienza di Torino Aug 01 2014 - Oct 30 2015

Italy

MD :: Hemathology

Publications

Chiara Frairia, Barbara Nicolino, Carolina Secreto, Emanuela Messa, Giulia Arrigo, Alessandro Busca, Marco Cerrano, Stefano D'Ardìa, Chiara Dellacasa, Andrea Evangelista, Roberto Freilone, Valentina Giai, Giorgio Priolo, Irene Urbino, Ernesta Audisio
Validation of National Early Warning Score and Quick Sequential (sepsis-related) Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapy. European journal of haematology (2023)
Vincenzo Apolito, Giulia Arrigo, Loic Vasseur, Matteo Olivi, Silvia Perrone, Valentina Giai, Carolina Secreto, Federica Di Biase, Maria Carla De Simone, Carolina Copia, Angela Gravetti, Roberto Freilone, Benedetto Bruno, Giuseppe Lanzarone, Eloise Beggiato, Chiara Frairia, Ernesta Audisio, Stefano D'Ardia, Dario Ferrero, Marco Cerrano, Felicetto Ferrara
Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax. British journal of haematology (2023)
Elena Crisà, Daniela Cilloni, Elena M Elli, Vincenzo Martinelli, Giuseppe A Palumbo, Novella Pugliese, Eloise Beggiato, Chiara Frairia, Marco Cerrano, Giuseppe Lanzarone, Monia Marchetti, Mauro Mezzabotta, Mario Boccadoro, Dario Ferrero
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib. British journal of haematology 182 (5) (2018)